Silencing the androgen receptor: New skills for antiandrogen oligonucleotide skin and hair therapy

被引：8
|
作者：
Dugour, Andrea [1 ]
Hagelin, Karin [1 ]
Smus, Cintia [1 ]
Balana, Maria Eugenia [1 ]
Kerner, Nestor [1 ]
机构：
[1] Ctr Ciencia & Tecnol, Fundac Pablo Cassara, RA-2468 Buenos Aires, DF, Argentina
来源：
JOURNAL OF DERMATOLOGICAL SCIENCE | 2009年 / 54卷 / 02期
关键词：
Antiandrogen oligonucleotides; Skin and hair; Cutaneous therapy; ALOPECIA; TRIAL;
D O I：
10.1016/j.jdermsci.2008.12.008
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：123 / 125
页数：3
相关论文
共 38 条
  • [21] RU58841 a new therapeutic agent affecting androgen receptor molecular interactions in human hair follicles
    Sawaya, ME
    HAIR RESEARCH FOR THE NEXT MILLENIUM, 1996, 1111 : 355 - 358
  • [22] Hyperactive androgen receptor in prostate cancer: What does it mean for new therapy concepts?
    Culig, Z
    Hobisch, A
    Hittmair, A
    Peterziel, H
    Radmayr, C
    Bartsch, G
    Cato, ACB
    Klocker, H
    HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (03) : 781 - 786
  • [23] RNA-levels of 5 alpha-reductase and androgen receptor in human skin, hair follicles and follicle-derived cells
    Eicheler, W
    Huth, A
    Happle, R
    Hoffmann, R
    HAIR RESEARCH FOR THE NEXT MILLENIUM, 1996, 1111 : 327 - 331
  • [24] 6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells
    Zhang, Xiaowei
    Castanotto, Daniela
    Nam, Sangkil
    Horne, David
    Stein, Cy
    MOLECULAR THERAPY, 2017, 25 (01) : 79 - 91
  • [25] Validity and Future of Primary Androgen Deprivation Therapy in Prostate Cancer. Integration in the Era of New Agents Targeting the Androgen Receptor
    Carballido, Joaquin
    ARCHIVOS ESPANOLES DE UROLOGIA, 2023, 76 (01): : 1 - 28
  • [26] IRON-DEFICIENT MILK OF HEPHAESTIN KNOCKOUT MICE UNDERLIES A HAIR LOSS PHENOTYPE IN PUPS ASSOCIATED WITH INCREASED ANDROGEN RECEPTOR EXPRESSION IN THE SKIN
    Sobh, Amin
    Page, Kathryn
    Lachenauer, Erica
    Luong, Julie
    Han, Chenchen
    Irimagawa, Hiroko
    He, Yuanchi
    Killilea, David
    Frazer, David
    Anderson, Gregory
    Fuqua, Brie
    Vulpe, Chris
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (03) : E54 - E54
  • [27] Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5α-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats:: New approach for benign prostate hyperplasia
    Gao, WQ
    Kearbey, JD
    Nair, VA
    Chung, KW
    Parlow, AF
    Miller, DD
    Dalton, JT
    ENDOCRINOLOGY, 2004, 145 (12) : 5420 - 5428
  • [28] Antarlides: A New Type of Androgen Receptor (AR) Antagonist that Overcomes Resistance to AR-Targeted Therapy
    Saito, Shun.
    Fujimaki, Takahiro
    Panbangred, Watanalai
    Igarashi, Yasuhiro
    Imoto, Masaya
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (08) : 2728 - 2732
  • [29] EORTC 2238 "De-Escalate": a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitors
    Grisay, Guillaume
    Turco, Fabio
    Litiere, Saskia
    Fournier, Beatrice
    Patrikidou, Anna
    Gallardo, Enrique
    Mcdermott, Ray
    Alanya, Ahu
    Gillessen, Silke
    Tombal, Bertrand
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [30] Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
    Fiorica, Francesco
    Buttigliero, Consuelo
    Grigolato, Daniela
    Muraro, Marco
    Turco, Fabio
    Munoz, Fernando
    Tucci, Marcello
    CURRENT ONCOLOGY, 2022, 29 (12) : 9511 - 9524
1234